Astrazeneca
Astrazeneca News
'Lynparza': AstraZeneca India gets DCGI's nod to market drug treating breast cancer
With the DCGI's nod, Lynparza is now approved in the US, EU, Japan, India and several other countries for the treatment of early-stage breast cancer
Health
Linking COVID-19 vaccine with Monkeypox: Busting the myths
The virus has been named Monkeypox because initially it was detected in a monkey
Proud to say, I have the Indian jab in my arms and it did me good: Boris Johnson thanks India
UK PM Boris Johnson, who is on a two-day visit in India, thanks Prime Minister Narendra Modi for a grand welcome in his home-state Gujarat on Thursday
Serum Institute CEO Adar Poonawalla urges Novak Djokovic to get vaccinated, tweet goes viral
World number one tennis player Novak Djokovic was barred from participating in the Australian Open as he refused to get vaccinated against coronavirus
Serum Institute pledges over $66 million to Oxford University for vaccine research centre
The main focus of the research taking place in the Poonawalla Building will be vaccinology and it will house over 300 research scientists
WHO pushes back decision on Covaxin's EUL again, seeks more data
The UN health body said that the TAG expects to reconvene for the final risk-benefit assessment on 3 November
Tedros Adhanom, Mansukh Mandaviya discuss emergency use listing of Covaxin on phone call
The WHO director general said he also discussed vaccine equity issues, resumption of SII/AstraZeneca vaccine supplies, Covaxin EUL process and technology and license sharing through C-TAP
WHO chief and Health Minister discuss Covaxin's EUL, vaccine equity and supplying COVAX during virtual call
India will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the Vaccine Maitri' programme and to meet its commitment to the COVAX global pool.
AstraZeneca's COVID antibody drug shows reduction in severe infection, death in its phase 3 trials
The treatment - AZD7442 - is made from a combination of two antibodies and was given to 903 participants with 90 percent of them having a high risk of progression to severe COVID-19.
COVID vaccines effective at preventing severe infection, 90 percent less likely to be hospitalised or die finds study
This study is one of the largest research conducted with them looking at data from 22 million people over 50 years starting in December 2020.
AstraZeneca seeks FDA's emergency use approval for its COVID-19 antibody treatment drug
Late-stage human trials showed that AstraZeneca’s antibody drug reduced the risk of developing symptomatic COVID-19 by 77 percent.
COVID-19 vaccine certificate controversy: Britain can antagonise India at its own peril
India needs to be an equal partner on a host of other responses – not the least among them is our Co-Win software. In this situation, Britain can antagonise India at its own peril. And the ramifications of it will not be restricted to the Covid response alone.
COVID-19: AstraZeneca vaccine creator says mass boosters may be unnecessary
Oxford University Professor Sarah Gilbert told The Telegraph newspaper that immunity from the vaccine was holding up well — even against the delta variant
How does the COVID-19 vaccine work once it enters the body – Roadmap for kids and adults
As soon as the vaccine is inside the tissue cells, it uses the instructions to create spike proteins. This process usually takes less than 12 hours.
Azerbaijan trial studying effects of combined Sputnik and AstraZeneca vaccines reports positive results
When contacted for their response to the latest development, both Serum Institute of India and Dr Reddy's Laboratories refused to comment at this time.
AstraZeneca's vaccine effectiveness against COIVD-19 lasts longer than Pfizer's finds study
Pfizer had "greater initial effectiveness" but saw "faster declines in protection against high viral burden and symptomatic infection."
Serum Institute's Covishield vaccine gets nod from France for travel
The move to accept visitors vaccinated with AstraZeneca's vaccine made by SII came after a global outcry over the fact that the EU's selective approval was discriminatory
India pulled back vaccine supply to COVAX due to surge of cases inside country, says USAID administrator
The shortage is going to end soon as the US has purchased the Pfizer vaccine, which will start to come online in August, Samantha Power told a Congressional Committee
Delta variant cases mark 32% weekly increase in UK COVID figures, vaccine protection high, say officials
Overall, the Delta variant first identified in India currently accounts for approximately 99 percent of cases that are sequenced across the UK, followed by the local Alpha variant of concern
COVID-19 Fact Check: What does science say about mixing vaccines?
While the studies show positive results of mixing AstraZeneca and Pfizer, there are still doubts that linger.